The EOSC4Cancer project — with contributions from Martijn, Mahlet, and Stefan — has been featured by the Research Executive Agency as a success story in AI-driven health research.
The project EOSC4Cancer (A European-wide foundation to accelerate data-driven cancer research) brings together a large European consortium aiming to make diverse cancer-related data — genomics, imaging, medical, clinical, environmental and socio-economic — accessible across borders, enabling analytics and AI workflows on that data.
It provides the foundation for a federated, interoperable European infrastructure that supports secure, FAIR data sharing and reuse to accelerate cancer research.
Recently, EOSC4Cancer was highlighted in the Research Executive Agency (REA) article “Facing the future – AI-driven research projects overcoming real-life challenges” as a success story in the health domain.
The recognition underscores the project’s impact in applying AI and data science to real-world cancer research challenges.
Key highlights of EOSC4Cancer:
- Duration: September 2022 – February 2025
- Builds interoperable systems for federated, privacy-preserving cancer data access and analysis across Europe
- Covers the full patient journey — from prevention to diagnosis and treatment
- Brings together 29 partners from 13 countries
- Coordinated by the Barcelona Supercomputing Center (BSC)
Within the project, members of our group — Martijn, Mahlet, and Stefan — contributed to work packages focusing on data integration and AI-driven analysis, supporting EOSC4Cancer’s mission to make cancer data more usable and impactful for research across Europe.
This achievement highlights our group’s continued involvement in large-scale European initiatives driving the future of data-driven biomedical research.
Further reading: